{
    "clinical_study": {
        "@rank": "102705", 
        "arm_group": {
            "arm_group_label": "Denosumab and/or teriparatide treatment", 
            "arm_group_type": "Experimental", 
            "description": "Denosumab and/or teriparatide treatment in osteoporotic patients"
        }, 
        "brief_summary": {
            "textblock": "It has not been well known about the changes of bone metabolic markers, bone mineral density\n      and other bone-related markers after teriparatide and/or denosumab treatment in Japanese\n      osteoporotic patients."
        }, 
        "brief_title": "Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients", 
        "condition": "Osteoporosis", 
        "condition_browse": {
            "mesh_term": "Osteoporosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Osteoporotic patients\n\n        Exclusion Criteria:\n\n          -  Kidney disease,  parathyroid disease, congenital bone metabolic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02156960", 
            "org_study_id": "Deno-PTH2365"
        }, 
        "intervention": [
            {
                "arm_group_label": "Denosumab and/or teriparatide treatment", 
                "description": "To examine the effectiveness of denosumab in osteoporotic patients", 
                "intervention_name": "Denosumab treatment in osteoporotic patients", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Denosumab and/or teriparatide treatment", 
                "description": "To examine the effectiveness of teriparatide in osteoporotic patients", 
                "intervention_name": "Teriparatide treatment in osteoporotic patients", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Denosumab and/or teriparatide treatment", 
                "description": "To examine the effectiveness of denosumab and teriparatide in osteoporotic patients", 
                "intervention_name": "Denosumab and teriparatide treatment in osteoporotic patients", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Teriparatide"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "contact": {
                "email": "yxn14@aol.jp", 
                "last_name": "Yukio Nakamura, MD, PhD", 
                "phone": "+81-263-37-2659"
            }, 
            "facility": {
                "address": {
                    "city": "Matsumoto", 
                    "country": "Japan", 
                    "state": "Nagano", 
                    "zip": "3908621"
                }, 
                "name": "Yukio Nakamura"
            }, 
            "investigator": {
                "last_name": "Yukio Nakamura, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "yxn14@aol.jp", 
            "last_name": "Yukio Nakamura, MD, PhD", 
            "phone": "+81-263-37-2659"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Bone mineral density will be examined every 4-6 months to evaluate the suitability of the drug.", 
            "measure": "Changes of bone mineral density", 
            "safety_issue": "Yes", 
            "time_frame": "every 4-6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02156960"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shinshu University", 
            "investigator_full_name": "Yukio Nakamura", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Bone turnover markers will be examined every 3-6 months to evaluate the suitability of the drug.", 
            "measure": "Changes of bone turnover markers", 
            "safety_issue": "Yes", 
            "time_frame": "every 3-6 months"
        }, 
        "source": "Shinshu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shinshu University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}